Sterling Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
921
-147
-14% -$50.3K 0.08% 141
2026
Q1
$376K Sell
1,068
-446
-29% -$159K 0.11% 125
2025
Q4
$462K Buy
1,514
+487
+47% +$154K 0.13% 102
2025
Q3
$290K Buy
+1,027
New +$298K 0.09% 110
2025
Q2
Sell
-2,071
Closed -$645K 141
2025
Q1
$645K Buy
+2,071
New +$612K 0.22% 81
2024
Q4
Sell
-2,109
Closed -$680K 131
2024
Q3
$680K Buy
2,109
+13
+0.6% +$4.25K 0.24% 69
2024
Q2
$655K Buy
2,096
+448
+27% +$132K 0.26% 65
2024
Q1
$469K Sell
1,648
-327
-17% -$95.7K 0.22% 80
2023
Q4
$569K Buy
1,975
+288
+17% +$78.5K 0.29% 66
2023
Q3
$453K Sell
1,687
-89
-5% -$22.2K 0.26% 70
2023
Q2
$394K Sell
1,776
-246
-12% -$57.1K 0.21% 88
2023
Q1
$489K Sell
2,022
-400
-17% -$98.2K 0.29% 65
2022
Q4
$636K Buy
2,422
+68
+3% +$18.2K 0.39% 48
2022
Q3
$531K Sell
2,354
-142
-6% -$34.4K 0.39% 48
2022
Q2
$607K Sell
2,496
-48
-2% -$11.8K 0.46% 39
2022
Q1
$615K Buy
2,544
+1,225
+93% +$281K 0.41% 50
2021
Q4
$297K Buy
+1,319
New +$278K 0.2% 106

Other funds holding AMGN

Sterling Investment Counsel's AMGN Position: Q2 2026 in Review

Sterling Investment Counsel reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $50.3K and leaving 921 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #141.

Sterling Investment Counsel first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $680K in Q3 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sterling Investment Counsel held 921 shares of Amgen worth $334K as of Q2 2026.
  • Sterling Investment Counsel sold 147 Amgen shares in Q2 2026, an estimated $50.3K.
  • Amgen made up 0.08% of Sterling Investment Counsel's portfolio in Q2 2026, its #141 holding.
  • Sterling Investment Counsel first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
  • Sterling Investment Counsel's Amgen position peaked at $680K in Q3 2024.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.